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Abstract
Background: Comorbid depression in diabetes has been suggested as one of the possible causes of an
inadequate glycemic control. The purpose of this study was to investigate the association between major
depression and the glycemic control of type 2 diabetes mellitus (T2DM).
Methods: Seventy T2DM patients were evaluated. They underwent a psychiatric examination using the following
instruments: Structured Clinical Interview for DSM-IV and Beck Depression Inventory. The diabetes status was
assessed in the short-term (glycemia, glycated hemoglobin) clinical control.
Results: The presence of current depression was observed in 18.6% (13/70). In addition, type 2 diabetes patients
who displayed depression evidenced higher levels of glycated hemoglobin (8.6 ± 2.0 vs. 7.5 ± 1.8; p = 0.05) when
compared to those who did not exhibit a mood disorder.
Conclusions: In our sample, the presence of depression seems to impact on the short-term control of T2DM. The
authors discuss the clinical utility of these findings in the usual treatment of diabetes.
Background
According to the American Diabetes Association (ADA)
guidelines, patients with diabetes should maintain low
levels of glycated hemoglobin (A1C), blood pressure and
low-density lipoprotein [1]. However, only 10% of the
patients meet all those three goals simultaneously [2].
As a consequence, the control of the disease is inade-
quate, leading to an increase of the morbidity and mor-
tality [3].
Several factors may account for an unsatisfactory meta-
b o l i cc o n t r o lo fD M .A m o n gt h e mi ti si m p o r t a n tt o
emphasize the relevance of the occurrence of a psychiatric
comorbidity. The presence of depression in a patient with
diabetes has been suggested as one of the possible causes
of an inadequate metabolic control, especially for those
patients who cannot achieve an adequate glycemic control
despite intensive medical recommendations.
Several studies observed higher rates of depression in
patients with diabetes and tried to demonstrate the asso-
ciation between the presence of depressive symptoms
and an increased prevalence of clinical complications of
the DM. Anderson et al. conducted a meta-analysis of 42
studies investigating the association between depression
and diabetes [4]. The authors found that the presence of
diabetes doubles the odds of having depression. This risk
remained even after controlling for both types of diabetes
or different diagnostic methods for depression across stu-
dies. O’Connor et al. followed a retrospective cohort of
patients with diabetes to investigate the prevalence of
depression [5]. The authors observed an increase preva-
lence of depression in patients with diabetes compared to
a non-diabetic sex- and age-matched control group.
Furthermore, several authors found an association
between depression and a poor metabolic control of
T2DM. In a meta-analytic review of the literature, Lust-
man et al. investigated the association between depression
and diabetes glycemic control [6]. The authors observed
that depression was significantly associated with hypergly-
cemia in patients with type 1 and type 2 diabetes (z = 5.4;
p < 0.0001). In the same line, de Groot et al., conducted a
meta-analysis examining the association between depres-
sion and diabetes outcomes [7]. Twenty-seven studies
were included and the authors found a significant associa-
tion between depression and clinical complications of
diabetes (p < 0.00001; z = 5.94).
The purpose of this study was to investigate the asso-
ciation between depression and the clinical control of
T2DM with respect to short-term (glycemia and A1C
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with diabetes.
Methods
Seventy type 2 diabetic outpatients, aged 30 to 65 years,
were assessed consecutively at the State Institute of Dia-
betes and Endocrinology of Rio de Janeiro. T2DM was
diagnosed according to ADA criteria [8]. All patients
underwent clinical and psychiatric evaluation. Exclusion
criteria included the presence of type 1 diabetes, gesta-
tional diabetes or secondary diabetes due to another dis-
ease, the use of medications likely to affect food intake
(appetite suppressants and other anti-obesity drugs) and
the incapacity to self-complete the questionnaires. The
Ethics Committee of the Institution approved the protocol
and written informed consent was obtained after the pro-
cedures involved in the study were fully explained.
Clinical Examination
Anthropometric examinations were made and laboratory
tests were obtained to assess the metabolic control of dia-
betes. For the short-term evaluation, fasting glycemia and
A1C levels were assessed. Glycemia was measured using a
colorimetric enzymatic method, and A1C levels were
determined using high-performance liquid chromatogra-
phy (HPLC; Variant turbo, Bio-Rad, National Glycohemo-
globin Standardization Program).
Psychiatric instruments
All subjects were interviewed by a psychiatrist (MP)
trained in the use of the Structured Clinical Interview for
DSM-IV, patient edition (SCID-P) [9]. This instrument
was used for the current and past diagnosis of depression.
The Beck Depression Inventory (BDI) was also applied to
provide a measure of severity of general psychopathology
[10]. Two studies evidenced that the BDI was an effective
screening test for major depression in diabetic patients.
Lustman et al. observed that both cognitive and somatic
items exhibited satisfactory psychometric properties [11].
In another study, Hermanns et al. screened 376 diabetic
patients for clinical depression [12]. The authors observed
that the BDI presented the best sensitivity (87%), com-
pared to Center of Epidemiological Studies-Depression
Scale (79%) and the Problem Areas in Diabetes question-
naire (81%), which assesses diabetes-specific distress. In
addition, the BDI has been translated and validated into
Portuguese, presenting good reliability [13].
Procedures
Patients who met the inclusion criteria were consecu-
tively evaluated. They were asked to complete the BDI,
and the SCID-P examination was performed. Laboratory
tests were subsequently performed.
Statistical Analysis
Continuous variables were expressed as means and stan-
dard deviation, and categorical data were expressed as
absolute and relative frequencies. Patients with depression
were compared to those with no general psychopathology
in terms of clinical and psychiatric characteristics. The
Mann-Whitney test was used to compare means of con-
tinuous variables, and the Chi-square test was used to ana-
lyze categorical variables. Correlations of BDI scores with
glycemia and A1C levels were made using Spearman’st e s t .
A significance level of 5% was adopted.
Results
In our sample, current depression was evidenced in 18.6%
(13/70) of the patients. Also, almost 36% of the patients
(25/70) of the patients had a past history of mood disor-
der, using the SCID-P (Table 1). Furthermore, patients
with current depression exhibited a greater severity of
depressive symptoms, using the BDI, when compared to
those who did not present depression at evaluation (22.9 ±
6.5 vs. 12.7 ± 9.0; p < 0.001). Also, none of the depressed
patients was receiving specific psychiatric or psychological
treatment. Table 1 displays several clinical characteristics
of the studied population. It is important to note that,
approximately half of the patients were using insulin at
the time of examination.
Patients who displayed depression were younger than
those who did not exhibit a mood disorder (49.5 ± 6.9 vs.
53.7 ± 6.6; p = 0.04). In the same way, type 2 diabetic
patients who evidenced current depression had higher
rates of insulin use than those without depression (27.8%
vs. 8.8%; p = 0.04).
Patients with T2DM who had depression had a poorer
glycemic control compared to patients without mood dis-
order (Figure 1), even after controlling for age and insulin
use. Conversely, patients who exhibited lifetime depres-
sion, but were not depressed at the time of evaluation, did
not display higher A1C levels compared to those patients
Table 1 Clinical variables of type 2 diabetes mellitus
patients
N (%; median ± sd)
BMI (kg/m
2) 30,56 ± 5.20
Normal 18.6
Overweight 31.4
Obese 50
Duration of diabetes (years) 13.36 ± 7.55
Insulin use 51.4
Glucose (mg/dl) 164.7 ± 75.9
Glycated hemoglobin (%) 7.72 ± 1.91
BDI 14.6 ± 9.5
BMI - Body Mass Index; BDI - Beck Depression Inventory
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7.6 ± 1.8; p = 0.57).
Discussion
In our study, almost 20% of patients with T2DM exhibited
current depression. Those diabetic patients with comorbid
depression had significantly poor glycemic control com-
pared to those without any mood disorder.
The prevalence of depression found in our study was
similar to that observed in other investigations [14,15].
However, some studies had showed that the elevated rates
of depression observed in diabetes were also associated to
others clinical variables than the presence of diabetes.
Pouwer et al. conducted a community-based cross-sec-
tional study to evaluate the prevalence of depression in
216 subjects with diabetes and 1184 subjects without any
chronic disease [16]. The authors found an increased pre-
valence of depression only in diabetic subjects who dis-
played a comorbid clinical disease. In another study, Kruse
et al. compared the prevalence of mental disorders
between 141 diabetic patients and 4,028 subjects without
diabetes in community sample [17]. The authors observed
that people with diabetes were not more likely to meet the
DSM-IV criteria for depression than subjects without dia-
betes when the findings were controlled for age, sex, mari-
tal status and socioeconomic status (OR = 1.41, 95% CI
[0.78-2.55]). Finally, in a recent study, O’Connor et al.
evaluated the association between depression and the
number of primary care visits in two large samples of dia-
betic patients and a non-diabetic control group [5]. The
authors found a negative correlation between the risk for
depression and the number of primary care visits the
patient attended.
It seems important to note the absence of specific
interventions to ameliorate depression in our sample of
T2DM patients. Indeed, the subdiagnosing and under-
treatment of depression in patients with comorbid phy-
sical illness has been reported in several studies, even
after the implementation of clinical-practice guideline to
improve recognition of depression in primary care
[18,19]. In a recent review, beliefs from physicians that
depression was a normal response to life events, the
clinician struggle to differentiate distress from depres-
sion and the subnotification of depressive symptoms
from the patients in order to avoid stigmatization, were
some of the barriers identified in the adequate manage-
ment of depression [20].
Besides the elevated prevalence of depression in dia-
betes, several authors observed an impact of depression on
glycemic control of diabetes. Skaff et al., evaluating 206
type 2 diabetic patients, showed that a daily negative
mood correlated positively with the fasting glucose level of
the next morning in men with T2DM (r = 0.17; p < 0.05)
[21]. In addition, Eren et al. examined the impact of
depression on clinical control of 104 T2DM patients [22].
The authors observed that the number of depressive epi-
sodes correlated positively with A1C levels. A longitudinal
study investigated the correlation between depression and
A1C levels in T2DM patients with and without depression
[23]. The authors observed that type 2 diabetic patients
with depression exhibited higher A1C levels compared to
patients without depression in all time points evaluated
(mean difference of 0.13; 95% CI [0.03-0.22]; p = 0.008). In
the same line with previous investigations, our study
found that patients with diabetes who displayed depression
had higher A1C levels compared to those without depres-
sion. However, patients with lifetime depression without
depressive symptoms at evaluation did not exhibited
higher A1C levels compared to those with clinical depres-
sion at examination. In a similar study, de Groot et al.,
evaluating 39 T2DM patients, also observed that type 2
diabetes patients with a lifetime history of major depres-
sion did not have significantly worse control than those
with no history of psychiatric illness [24].
Although the use of insulin was not associated with
glycemic control in our study, we observed that patients
who were using insulin had elevated rates of depression
compared to those who were using only oral hypoglice-
miants. Aikens et al. investigated the influence of treat-
ment regimen on the association between depression and
A1C levels [25]. The authors, evaluating 258 T2DM
patients, observed that depression was associated with
A1C levels in patients using insulin (beta = 0.35; p <
0.001) but not in patients using oral agents alone (beta =
-0.08; p = NS).
Some limitations of this study must be discussed. The
sample size was relatively small. In addition, inclusion of
others clinical variables such, number of clinical appoint-
ments and measures of medical and nutritional adherence
group could have helped in better understanding the role
of depression in our results. Also, the absence of control
for antidepressant use could have biased the severity of
Figure 1 Mean glycated hemoglobin (HbA1c) levels in type 2
diabetes patients with and without current depression.
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more piece of information regarding the impact of depres-
sion on the metabolic control of diabetes. Furthermore,
this is the first observational study on the association
between depression and glycemic control of T2DM in a
Brazilian clinical sample.
Conclusions
Our study is in line with previous investigations that
showed an inadequate glycemic control in the co-occur-
rence of depression and type 2 diabetes. Of note, the pre-
sence of psychiatric comorbidity in diabetic patients
should always be investigated and a carefully monitoring
of the metabolic control might be important of those indi-
viduals who exhibit clinical depression. Nevertheless, it
would be advantageous to have other longitudinal studies
to better understand the nature of those associations.
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